These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33604316)

  • 1. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
    Diesinger T; Lautwein A; Bergler S; Buckert D; Renz C; Dvorsky R; Buko V; Kirko S; Schneider E; Kuchenbauer F; Kumar M; Günes C; Genze F; Büchele B; Simmet T; Haslbeck M; Masur K; Barth T; Müller-Enoch D; Wirth T; Haehner T
    Can J Gastroenterol Hepatol; 2021; 2021():8854432. PubMed ID: 33604316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    Diesinger T; Buko V; Lautwein A; Dvorsky R; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Buckert D; Bergler S; Renz C; Schneider E; Kuchenbauer F; Kumar M; Günes C; Büchele B; Simmet T; Müller-Enoch D; Wirth T; Haehner T
    PLoS One; 2020; 15(7):e0235990. PubMed ID: 32701948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.
    Diesinger T; Lautwein A; Buko V; Belonovskaya E; Lukivskaya O; Naruta E; Kirko S; Andreev V; Dvorsky R; Buckert D; Bergler S; Renz C; Müller-Enoch D; Wirth T; Haehner T
    Physiol Rep; 2021 Mar; 9(6):e14795. PubMed ID: 33769703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of cytochrome P450 2E1 induces heme oxygenase-1 through ERK MAPK pathway.
    Gong P; Cederbaum AI; Nieto N
    J Biol Chem; 2003 Aug; 278(32):29693-700. PubMed ID: 12777398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CYP2E1 enhances sensitivity of hepG2 cells to fas-mediated cytotoxicity.
    Yan QG; Shi JG; Zhang F; Zhao QT; Pang XW; Chen R; Hu PZ; Li QL; Wang Z; Huang GS
    Cancer Biol Ther; 2008 Aug; 7(8):1280-7. PubMed ID: 18497573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2E1 increases the sensitivity of hepatoma cells to vitamin K2.
    Li L; Wang L; Song R; Chen G; Liu Y
    Int J Oncol; 2017 May; 50(5):1832-1838. PubMed ID: 28339022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
    Surapaneni KM; Priya VV; Mallika J
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2736-41. PubMed ID: 25317811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and properties of HepG2 cells that constitutively express CYP2E1.
    Wu D; Cederbaum AI
    Methods Mol Biol; 2008; 447():137-50. PubMed ID: 18369917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hepatofibrosis to hepatocarcinogenesis: Higher cytochrome P450 2E1 activity is a potential risk factor.
    Gao J; Wang Z; Wang GJ; Gao N; Li J; Zhang YF; Zhou J; Zhang HX; Wen Q; Jin H; Qiao HL
    Mol Carcinog; 2018 Oct; 57(10):1371-1382. PubMed ID: 29917271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress.
    Marí M; Cederbaum AI
    Hepatology; 2001 Mar; 33(3):652-61. PubMed ID: 11230746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity.
    Pérez MJ; Cederbaum AI
    Free Radic Biol Med; 2002 Jul; 33(1):111-27. PubMed ID: 12086689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
    Linhart K; Bartsch H; Seitz HK
    Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage.
    Lee M; Bae MA
    J Nutr Biochem; 2007 May; 18(5):348-54. PubMed ID: 16963249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of cytochrome P450 2E1 is associated with poor prognosis of hepatocellular carcinoma.
    Ho JC; Cheung ST; Leung KL; Ng IO; Fan ST
    Int J Cancer; 2004 Sep; 111(4):494-500. PubMed ID: 15239125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.
    Pang YY; Li JD; Gao L; Yang X; Dang YW; Lai ZF; Liu LM; Yang J; Wu HY; He RQ; Huang ZG; Xiong DD; Yang LH; Shi L; Mo WJ; Tang D; Lu HP; Chen G
    Cancer Med; 2020 Nov; 9(21):8004-8019. PubMed ID: 32931665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
    Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
    BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spin trapping agents (Tempol and POBN) protect HepG2 cells overexpressing CYP2E1 against arachidonic acid toxicity.
    Pérez MJ; Cederbaum AI
    Free Radic Biol Med; 2001 Apr; 30(7):734-46. PubMed ID: 11275473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
    Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
    Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.